ACCO GROUP HOLDINGS LTD- A (ACCL) Fundamental Analysis & Valuation

NASDAQ:ACCL • KYG0069D1108

1.56 USD
-0.03 (-1.89%)
At close: Mar 10, 2026
1.47 USD
-0.09 (-5.77%)
Pre-Market: 3/11/2026, 8:41:25 AM

This ACCL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, ACCL scores 5 out of 10 in our fundamental rating. ACCL was compared to 87 industry peers in the Professional Services industry. While ACCL has a great health rating, its profitability is only average at the moment. ACCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. ACCL Profitability Analysis

1.1 Basic Checks

  • ACCL had positive earnings in the past year.
  • In the past year ACCL had a positive cash flow from operations.
ACCL Yearly Net Income VS EBIT VS OCF VS FCFACCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 500K 1M 1.5M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 26.13%, ACCL belongs to the top of the industry, outperforming 98.85% of the companies in the same industry.
  • The Return On Equity of ACCL (46.72%) is better than 93.10% of its industry peers.
  • ACCL's Return On Invested Capital of 41.01% is amongst the best of the industry. ACCL outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ACCL is significantly above the industry average of 12.78%.
  • The last Return On Invested Capital (41.01%) for ACCL is well below the 3 year average (46.95%), which needs to be investigated, but indicates that ACCL had better years and this may not be a problem.
Industry RankSector Rank
ROA 26.13%
ROE 46.72%
ROIC 41.01%
ROA(3y)26.98%
ROA(5y)N/A
ROE(3y)54.52%
ROE(5y)N/A
ROIC(3y)46.95%
ROIC(5y)N/A
ACCL Yearly ROA, ROE, ROICACCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 20 40 60 80

1.3 Margins

  • ACCL has a better Profit Margin (20.90%) than 89.66% of its industry peers.
  • ACCL's Operating Margin of 22.09% is amongst the best of the industry. ACCL outperforms 88.51% of its industry peers.
  • ACCL's Gross Margin of 43.77% is fine compared to the rest of the industry. ACCL outperforms 60.92% of its industry peers.
Industry RankSector Rank
OM 22.09%
PM (TTM) 20.9%
GM 43.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACCL Yearly Profit, Operating, Gross MarginsACCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 10 20 30 40

8

2. ACCL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACCL is creating value.
  • The number of shares outstanding for ACCL remains at a similar level compared to 1 year ago.
  • ACCL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACCL Yearly Shares OutstandingACCL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 2M 4M 6M 8M 10M
ACCL Yearly Total Debt VS Total AssetsACCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 1M 2M 3M

2.2 Solvency

  • ACCL has an Altman-Z score of 10.91. This indicates that ACCL is financially healthy and has little risk of bankruptcy at the moment.
  • ACCL's Altman-Z score of 10.91 is amongst the best of the industry. ACCL outperforms 95.40% of its industry peers.
  • There is no outstanding debt for ACCL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.91
ROIC/WACC4.68
WACC8.76%
ACCL Yearly LT Debt VS Equity VS FCFACCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 500K 1M 1.5M 2M

2.3 Liquidity

  • ACCL has a Current Ratio of 1.82. This is a normal value and indicates that ACCL is financially healthy and should not expect problems in meeting its short term obligations.
  • ACCL's Current ratio of 1.82 is fine compared to the rest of the industry. ACCL outperforms 62.07% of its industry peers.
  • A Quick Ratio of 1.82 indicates that ACCL should not have too much problems paying its short term obligations.
  • ACCL has a better Quick ratio (1.82) than 64.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
ACCL Yearly Current Assets VS Current LiabilitesACCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 1M 2M 3M

1

3. ACCL Growth Analysis

3.1 Past

  • ACCL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.94%.
  • ACCL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.91%.
EPS 1Y (TTM)2.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.94%
Revenue 1Y (TTM)11.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCL Yearly Revenue VS EstimatesACCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 1M 2M 3M 4M

2

4. ACCL Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.29, the valuation of ACCL can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACCL is on the same level as its industry peers.
  • ACCL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.29
Fwd PE N/A
ACCL Price Earnings VS Forward Price EarningsACCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ACCL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ACCL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACCL is cheaper than 70.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 15.71
ACCL Per share dataACCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

  • ACCL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ACCL Dividend Analysis

5.1 Amount

  • No dividends for ACCL!.
Industry RankSector Rank
Dividend Yield 0%

ACCL Fundamentals: All Metrics, Ratios and Statistics

ACCO GROUP HOLDINGS LTD- A

NASDAQ:ACCL (3/10/2026, 8:04:45 PM)

Premarket: 1.47 -0.09 (-5.77%)

1.56

-0.03 (-1.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.32%
Inst Owner ChangeN/A
Ins Owners5.23%
Ins Owner ChangeN/A
Market Cap21.76M
Revenue(TTM)4.89M
Net Income(TTM)1.02M
AnalystsN/A
Price TargetN/A
Short Float %14.77%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.29
Fwd PE N/A
P/S 4.45
P/FCF 14.37
P/OCF 14.15
P/B 9.95
P/tB 9.95
EV/EBITDA 15.71
EPS(TTM)0.07
EY4.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY6.96%
OCF(TTM)0.11
OCFY7.07%
SpS0.35
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.5
Profitability
Industry RankSector Rank
ROA 26.13%
ROE 46.72%
ROCE 46.26%
ROIC 41.01%
ROICexc N/A
ROICexgc N/A
OM 22.09%
PM (TTM) 20.9%
GM 43.77%
FCFM 30.99%
ROA(3y)26.98%
ROA(5y)N/A
ROE(3y)54.52%
ROE(5y)N/A
ROIC(3y)46.95%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)52.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 15.57%
Cap/Sales 0.47%
Interest Coverage 250
Cash Conversion 125.16%
Profit Quality 148.27%
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 10.91
F-Score5
WACC8.76%
ROIC/WACC4.68
Cap/Depr(3y)7.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.24%
Cap/Sales(5y)N/A
Profit Quality(3y)125.27%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.77%
OCF growth 3YN/A
OCF growth 5YN/A

ACCO GROUP HOLDINGS LTD- A / ACCL FAQ

Can you provide the ChartMill fundamental rating for ACCO GROUP HOLDINGS LTD- A?

ChartMill assigns a fundamental rating of 5 / 10 to ACCL.


Can you provide the valuation status for ACCO GROUP HOLDINGS LTD- A?

ChartMill assigns a valuation rating of 2 / 10 to ACCO GROUP HOLDINGS LTD- A (ACCL). This can be considered as Overvalued.


What is the profitability of ACCL stock?

ACCO GROUP HOLDINGS LTD- A (ACCL) has a profitability rating of 6 / 10.


Can you provide the financial health for ACCL stock?

The financial health rating of ACCO GROUP HOLDINGS LTD- A (ACCL) is 8 / 10.